期刊文献+

70例真菌血症的临床特点分析 被引量:29

The clinical characteristics of 70 cases of fungemia
原文传递
导出
摘要 目的评价北京协和医院真菌血流感染患者病原学及临床特点。方法回顾性分析北京协和医院2008至2010年真菌血流感染患者的微生物学和临床资料。统计分析采用SPSSl7.0软件。结果本组70例均存在基础疾病和潜在危险因素的患者确诊为真菌血流感染,40例(57.1%)为单数菌感染,30例(42.9%)住院期间合并细菌性血流感染。从70例患者的血培养中共分离122株病原体,72株真菌,50株细菌;念珠菌61株(84.7%),占绝对优势,白念珠菌31株(50.8%),非白念珠菌30株(49.2%)。分析真菌血症的原发感染来源,35例(50.0%)原发真菌血症,18例(25.7%)同时存在下呼吸道定植,10例(14.3%)引起中心静脉导管相关真菌血症,3例(4.3%)继发于腹腔真菌感染,另有4例(5.7%)存在多个部位相同真菌定植。住院期间死亡37例,粗病死率为52.9%,真菌血症所致的直接病死率为32.9%。单因素分析显示,ICU治疗(χ2=15.136,P〈0.001)、30d内手术史(χ2=3.540,P=0.060)、有创机械通气(χ2=4.450,P=0.035)与住院期间死亡相关;住院期间合并细菌性血流感染(χ2=5.657,P=0.017)、循环系统疾病(χ2=3.399,P=0.065)、ICU治疗(X2=4.955,P=0.026)增加归因病死率。多因素分析中,ICU治疗增加真菌血流感染患者住院期间死亡风险,30d内手术史与住院期间死亡负相关;ICU治疗和住院期间合并细菌性血流感染增加真菌血症患者的归因病死率。结论真菌血症多发生于有一定基础疾病的患者,常伴随细菌血流感染。出现真菌血症的患者预后差,半数以上病人死亡,ICU治疗同时增加真菌血流感染的住院期间死亡和归因死亡风险,住院期间合并细菌性血流感染增加归因病死率,30d内手术史与住院期间死亡负相关。 Objective To evaluate the etiological and clinical characteristics of fungemia in Peking Union Medical College Hospital. Methods Microbial and clinical information of patients with fungemia consulted in Peking Union Medical College Hospital during 2008 to 2010 were retrospectively analyzed. Results A total of 70 patients were diagnosed with fungemia, and 100% of them had underlying diseases or potential risk factors. Of them, 40 ( 57.1% ) patients were monomicrobial fungemia, and the other 30 (42. 9% ) patients with positive blood cultures were caused by at least two different microbes during hospitalization. Among 122 strains of microbes isolated from blood cultures, 72 were fungi and 50 were bacteria. Among the isolated fungi, 61 (84. 7% ) were Candida species, 31 (50. 8% ) were Candida albicans and 30 (49.2%) were non-albicans. According to the colonization or infected sites other than blood of the isolated fungi, 35 cases (50. 0% ) were primary fungemia; 18 (25.7%) were colonizing at lower respiratory tract simultaneously; 10 ( 14. 3% ) caused central-line related fungemia; 3 (4. 3 % ) were secondary to intra- abdominal fungal infection; and another 4 (5.7%) isolates had multiple colonization sites. During hospitalization, 37 cases died with a crude mortality rate of 52.9%, and 22 (32. 9% ) died of fungemia itself. In single factor analysis, ICU hospltalizahon(X2= 15. 136, P 〈 0. 001 ), operation history within 30 days (X2 =3. 540, P =0. 060) and invasive mechanical ventilation(X2 =4. 450, P =0. 035) were related to crude mortality. Bacteremia during hospitalization (X2 = 5. 657, P = 0. 017), circulatory underlying diseases(X2 = 3. 399, P = 0. 065) and ICU treatment (X2 = 4. 955, P = 0. 026) increased attributable mortality. In the multivariate analysis, ICU history increased mortality during hospitalization, however, the operation history within 30 days was independently irrelevant to crude mortality during hospitalization. ICU history and bacteremia during hospitalization were independently correlated to attribution mortality of the patients with fungemia. Conclusions Fungemia, usually accompanied with bacteremia, occurs often in the patients with underlying diseases. Patients with fungemia have poor prognosis and more than 50% patients die. ICU history increases the risk both to crude and attributable mortality. The patients with fungemia who had polymicrobial bloodstream infection have a higher attribution mortality. Operation history within 30 days is independently negatively correlated to attributable mortality.
出处 《中华内科杂志》 CAS CSCD 北大核心 2012年第12期952-956,共5页 Chinese Journal of Internal Medicine
关键词 真菌 真菌血症 死亡率 危险因素 Fungi Fungemia Mortality Risk factors
  • 相关文献

参考文献2

二级参考文献12

  • 1Pfaller MA, Diekema DJ, Jones RN,et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program [J]. J Clin Microbiol, 2001, 39 (9): 3254-3259.
  • 2Bassetti M, Trecarichi EM, Righi E, et al. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals [J]. Diagn Microbiol Infect Dis, 2007,58 (3) :325-331.
  • 3Tortorano AM, Peman J, Bernhardt H,et al. Epidemiology of candidaemia in Europe: results of 28 month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study[J]. Eur J Clin Microbiol Infect Dis,2004,23 (4):317-322.
  • 4Almirante B, Rodriguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, spain, from 2002 to 2003[J]. J Clin Microbiol, 2005,43(4) 1829-1835.
  • 5Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Improving survival of patients with candidaemia:analysis of prognostic factors from a long-term, nationwide study in Iceland[J]. Scand J Infect Dis,2005,37(2) :111-120.
  • 6Peman J, Canton E, Gobernado M; et al. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain[J]. Eur J Clin Microbiol Infect Dis,2005,24(1): 23-30.
  • 7Kontoyiannis DP, Vaziri I, Hanna HA, et al. Risk factors for Candida tropiealis fungemia in patients with cancer[J]. Clin Infect Dis,2001,33(10) :1676-1681.
  • 8Tumbarello M, Posteraro B, Trecarichi EM, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia [J]. J Clin Microbiol, 2007,45 (6) : 1843-1850.
  • 9Vardakas KZ, Samonis G, Michalopoulos A, et al. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta analysis of randomized, placebocontrolled trials[J]. Crit Care Med,2006,34(4) :1216-1224.
  • 10Parkins MS, Sabuda DM, Elsayed S, et al. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections[J]. J Antimicrob Chemother, 2007,60(3) : 613-618.

共引文献436

同被引文献224

引证文献29

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部